(NASDAQ: IVA) Inventiva Sa's forecast annual revenue growth rate of -1.17% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.64%.
Inventiva Sa's revenue in 2024 is $25,177,173.On average, 3 Wall Street analysts forecast IVA's revenue for 2024 to be $290,597,740, with the lowest IVA revenue forecast at $227,224,919, and the highest IVA revenue forecast at $410,151,401. On average, 1 Wall Street analysts forecast IVA's revenue for 2025 to be $312,694,842, with the lowest IVA revenue forecast at $312,694,842, and the highest IVA revenue forecast at $312,694,842.
In 2026, IVA is forecast to generate $1,481,652,393 in revenue, with the lowest revenue forecast at $1,481,652,393 and the highest revenue forecast at $1,481,652,393.